Literature DB >> 8556707

p53 functional loss in a colon cancer cell line with two missense mutations (218leu and 248trp) on separate alleles.

A Rand1, K S Glenn, C P Alvares, M B White, S M Thibodeau, W E Karnes.   

Abstract

We have sequenced p53 in three colon cancer cell lines capable of autonomous proliferation. SNU-C1 and SNU-C4 cells, whose autonomous growth is dependent upon autocrine stimulation of epidermal growth factor receptor (EGFR), had wildtype p53 sequence of exons 4-9. In contrast, an EGFR ligand-independent cell line, SNU-C5, had heterozygous missense mutations affecting codons 218 (valine to leucine) and 248 (arginine to tryptophan) of p53. Bacterial cloning of p53 from SNU-C5 cells showed that the 248trp and 218leu mutants were both expressed and on separate alleles. 248trp is a common 'hot spot' mutant of p53 with variable dominant negative activity depending on the celullar context. Valine 218, in contrast, is rarely affected by mutation in cancers and is located in a region of the hydrophobic core domain away from 'hot spot' DNA contact sights. However, valine 218 is completely conserved across species, prompting us to investigate the function of 218leu in SNU-C5 cells. SNU-C5 cells exhibited complete loss of normal p53 function as evidenced by over-expression of p53 protein and by failure to show induction of p53, waf-1, mdm-2 or G1/S arrest in response to the DNA damaging agent, bleomycin. In a yeast p53 functional assay (FASAY), 50% of the clones were unable to transactivate a p53-specific promoter required for yeast colony expansion at 25, 30 or 37 degrees C. Sequencing of the p53 insert from several randomly selected wild-type and mutant yeast clones revealed that 218leu-bearing clones retained their ability to transactivate the p53-specific promoter. As expected, the 248trp-bearing clones lost this function. These data indicate that although 218leu retains normal transactivation activity on a p53 promoter in yeast at physiological temperatures, it is not capable of normal p53 function in the presence of a 248trp allele in SNU-C5 cells. It remains unclear whether the strong dominant negative activity of 248trp in SNU-C5 cells is related to the cellular context or to an unresolved abnormality of 218leu function.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8556707

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Tumor suppressor FOXO3 mediates signals from the EGF receptor to regulate proliferation of colonic cells.

Authors:  Wentao Qi; Christopher R Weber; Kaarin Wasland; Hemant Roy; Ramesh Wali; Suhasini Joshi; Suzana D Savkovic
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-25       Impact factor: 4.052

2.  Biology of SNU cell lines.

Authors:  Ja-Lok Ku; Jae-Gahb Park
Journal:  Cancer Res Treat       Date:  2005-02-28       Impact factor: 4.679

Review 3.  "P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences".

Authors:  Emad F Eskander; Ahmed A Abd-Rabou; Shaymaa M M Yahya; Ashraf El Sherbini; Mervat S Mohamed; Olfat G Shaker
Journal:  Indian J Clin Biochem       Date:  2013-04-04

4.  Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.

Authors:  Wentao Qi; Christopher R Weber; Kaarin Wasland; Suzana D Savkovic
Journal:  BMC Cancer       Date:  2011-06-03       Impact factor: 4.430

5.  Up-regulation of cyclooxygenase-2-derived prostaglandin E(2) in colon cancer cells resistant to 5-fluorouracil.

Authors:  Cheol Hee Choi; Tae Bum Lee; Yeon Ah Lee; Suk Choi; Kyung Jong Kim
Journal:  J Korean Surg Soc       Date:  2011-08-03

6.  Hot-spot mutations in the p53 gene of liver nodules induced in rats fed DL-ethionine with a methyl-deficient diet.

Authors:  T Tsujiuchi; L Yeleswarapu; Y Konishi; B Lombardi
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Comparative Study of Autophagy in Oxaliplatin-Sensitive and Resistant SNU-C5 Colon Cancer Cells.

Authors:  Sun-Jin Boo; Mei Jing Piao; Kyoung Ah Kang; Ao Xuan Zhen; Pincha Devage Sameera Madushan Fernando; Herath Mudiyanselage Udari Lakmini Herath; Seung Joo Lee; Seung Eun Song; Jin Won Hyun
Journal:  Biomol Ther (Seoul)       Date:  2022-05-25       Impact factor: 4.231

8.  TP53 codon 72 Gene Polymorphism Paradox in Associated with Various Carcinoma Incidences, Invasiveness and Chemotherapy Responses.

Authors:  Hung-Yu Lin; Chun-Hsiung Huang; Wen-Jen Wu; Li-Ching Chang; For-Wey Lung
Journal:  Int J Biomed Sci       Date:  2008-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.